1. Home
  2. QH vs GDTC Comparison

QH vs GDTC Comparison

Compare QH & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

QH

Quhuo Limited American Depository Shares

HOLD

Current Price

$3.35

Market Cap

10.1M

ML Signal

HOLD

Logo CytoMed Therapeutics Limited

GDTC

CytoMed Therapeutics Limited

SELL

Current Price

$0.88

Market Cap

10.4M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
QH
GDTC
Founded
2012
2018
Country
China
Singapore
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.1M
10.4M
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
QH
GDTC
Price
$3.35
$0.88
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
10.3K
★ 19.4K
Earning Date
10-27-2026
04-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$2.86
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.07
$0.68
52 Week High
$12.81
$3.68

Technical Indicators

Market Signals
Indicator
QH
GDTC
Relative Strength Index (RSI) 33.75 46.48
Support Level $3.00 $0.76
Resistance Level $4.07 $1.07
Average True Range (ATR) 0.27 0.12
MACD -0.00 -0.01
Stochastic Oscillator 30.57 41.71

Price Performance

Historical Comparison
QH
GDTC

About QH Quhuo Limited American Depository Shares

Quhuo Ltd is a gig economy platform focusing on local life services in China. It provide tech-enabled, end-to-end operational solutions to consumer service businesses, including on-demand delivery solutions, mobility service solutions, housekeeping and accommodation solutions, and other services. Its three operating segments, include (i) on-demand delivery solutions, (ii) mobility service solutions, and (iii) housekeeping and accommodation solutions and other services. It generates maximum of its revenue from the on-demand delivery solutions segment.

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

Share on Social Networks: